Retailers accuse Takeda, TWi Pharmaceuticals of blocking generic competition for Dexilant
MLex Summary: Walgreen Co., The Kroger Co., Albertsons, and HEB filed a complaint accusing Takeda Pharmaceutical and Twi Pharmaceuticals of entering into an illegal reverse payment agreement to restrain competition in...To view the full article, register now.
Already a subscriber? Click here to view full article